My Quote Request
No products added yet
6505-01-514-9309
20 Products
XYLOCAINE MPF
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015149309
NSN
6505-01-514-9309
XYLOCAINE MPF
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015149309
NSN
6505-01-514-9309
MFG
ASTRAZENECA LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LIDOCAINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240400
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: USED TO NUMB AN AREA BEFORE SURGERY OR BEFORE ANOTHER MEDICAL PROCEDURE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
03-2324
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
03-2324
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 55.000 MICROGRAMS TRIAMCINOLONE ACETONIDE PER METERED SPRAY
ADMINISTRATION: INHALATION
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMCINOLONE ACETONIDE NASAL SPRAY 55 MCG (1) BOTTLE 16.5GM (120) ACTUATIONS
PRIMARY CONTAINER CONTENT QUANTITY: 16.500 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE WITH NASAL ADAPTER
SPECIAL FEATURES: FOR THE TREATMENT OF THE NASAL SYMPTOMS OF SEAONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F); 120 ACUTATIONS PER BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
6505NCM032027
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
6505NCM032027
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 55.000 MICROGRAMS TRIAMCINOLONE ACETONIDE PER METERED SPRAY
ADMINISTRATION: INHALATION
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMCINOLONE ACETONIDE NASAL SPRAY 55 MCG (1) BOTTLE 16.5GM (120) ACTUATIONS
PRIMARY CONTAINER CONTENT QUANTITY: 16.500 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE WITH NASAL ADAPTER
SPECIAL FEATURES: FOR THE TREATMENT OF THE NASAL SYMPTOMS OF SEAONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F); 120 ACUTATIONS PER BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NASACORT-AQ
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
NASACORT-AQ
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 55.000 MICROGRAMS TRIAMCINOLONE ACETONIDE PER METERED SPRAY
ADMINISTRATION: INHALATION
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMCINOLONE ACETONIDE NASAL SPRAY 55 MCG (1) BOTTLE 16.5GM (120) ACTUATIONS
PRIMARY CONTAINER CONTENT QUANTITY: 16.500 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE WITH NASAL ADAPTER
SPECIAL FEATURES: FOR THE TREATMENT OF THE NASAL SYMPTOMS OF SEAONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F); 120 ACUTATIONS PER BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00075-1506-16
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
NDC00075-1506-16
TRIAMCINOLONE ACETONIDE INHALATION AEROSOL
NSN, MFG P/N
6505015152457
NSN
6505-01-515-2457
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 55.000 MICROGRAMS TRIAMCINOLONE ACETONIDE PER METERED SPRAY
ADMINISTRATION: INHALATION
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMCINOLONE ACETONIDE NASAL SPRAY 55 MCG (1) BOTTLE 16.5GM (120) ACTUATIONS
PRIMARY CONTAINER CONTENT QUANTITY: 16.500 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE WITH NASAL ADAPTER
SPECIAL FEATURES: FOR THE TREATMENT OF THE NASAL SYMPTOMS OF SEAONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F); 120 ACUTATIONS PER BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
03-2468
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505015153167
NSN
6505-01-515-3167
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1000.000 UNITS HEPARIN SODIUM PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201204
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPARIN SODIUM INJECTION USP 1000 UNITS PER ML 10 ML 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PORCINE DERIVATIVE
Related Searches:
NDC00641-2440-45
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505015153167
NSN
6505-01-515-3167
NDC00641-2440-45
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505015153167
NSN
6505-01-515-3167
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1000.000 UNITS HEPARIN SODIUM PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201204
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPARIN SODIUM INJECTION USP 1000 UNITS PER ML 10 ML 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PORCINE DERIVATIVE
Related Searches:
NDC63323-0540-11
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505015153167
NSN
6505-01-515-3167
NDC63323-0540-11
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505015153167
NSN
6505-01-515-3167
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1000.000 UNITS HEPARIN SODIUM PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201204
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPARIN SODIUM INJECTION USP 1000 UNITS PER ML 10 ML 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PORCINE DERIVATIVE
Related Searches:
03-2529
METOCLOPRAMIDE TABLETS,USP
NSN, MFG P/N
6505015155548
NSN
6505-01-515-5548
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 564000
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOCLOPRAMIDE TABLETS USP 10MG UNIT DOSE 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
Related Searches:
NDC00182-1789-89
METOCLOPRAMIDE TABLETS,USP
NSN, MFG P/N
6505015155548
NSN
6505-01-515-5548
NDC00182-1789-89
METOCLOPRAMIDE TABLETS,USP
NSN, MFG P/N
6505015155548
NSN
6505-01-515-5548
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 564000
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOCLOPRAMIDE TABLETS USP 10MG UNIT DOSE 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
Related Searches:
03-2530
FLUOCINOLONE ACETONIDE CREAM,USP
NSN, MFG P/N
6505015158814
NSN
6505-01-515-8814
03-2530
FLUOCINOLONE ACETONIDE CREAM,USP
NSN, MFG P/N
6505015158814
NSN
6505-01-515-8814
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: TOPICAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 840600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINOLONE ACETONIDE CREAM TOPICAL ANTI-INFLAMMATORY 60 GRAM TUBE EA
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
SPECIAL FEATURES: 0.025% FLUOCINOLONE ACETONIDE CREAM; 60 GRAM TUBE; TOPICAL; ANTI-INFLAMMATORY,STEROIDAL
Related Searches:
NDC00168-0060-60
FLUOCINOLONE ACETONIDE CREAM,USP
NSN, MFG P/N
6505015158814
NSN
6505-01-515-8814
NDC00168-0060-60
FLUOCINOLONE ACETONIDE CREAM,USP
NSN, MFG P/N
6505015158814
NSN
6505-01-515-8814
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ADMINISTRATION: TOPICAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 840600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINOLONE ACETONIDE CREAM TOPICAL ANTI-INFLAMMATORY 60 GRAM TUBE EA
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
SPECIAL FEATURES: 0.025% FLUOCINOLONE ACETONIDE CREAM; 60 GRAM TUBE; TOPICAL; ANTI-INFLAMMATORY,STEROIDAL
Related Searches:
03-2735
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160959
NSN
6505-01-516-0959
03-2735
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160959
NSN
6505-01-516-0959
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500 MG BT 30S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR PROPHYLAXIS AND TREATMENT OF ACUTE ATTACKS OF MALARIA CAUSED BY PLASMODIUM VIVAX, P MALARIAE, P OVALE AND SUSCEPTIBLE STRAINS OF P FALCIPARUM; EXTRAINTESTINAL AMEBIASIS; WITH CHILD PROOF CAP; NSN WAS CREATED TO PERMIT INVENTROY MANAGEMENT OF THE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: REPACKAGED DOSAGE FORM. PACKAGE OF 30 PREPARED BY REPACKAGING THE BULK PRODUCT. THE NSN IS NOT PROCURABLE, DO NOT REQUISITION
Related Searches:
CHLOROQUINE
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160959
NSN
6505-01-516-0959
CHLOROQUINE
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160959
NSN
6505-01-516-0959
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500 MG BT 30S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR PROPHYLAXIS AND TREATMENT OF ACUTE ATTACKS OF MALARIA CAUSED BY PLASMODIUM VIVAX, P MALARIAE, P OVALE AND SUSCEPTIBLE STRAINS OF P FALCIPARUM; EXTRAINTESTINAL AMEBIASIS; WITH CHILD PROOF CAP; NSN WAS CREATED TO PERMIT INVENTROY MANAGEMENT OF THE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: REPACKAGED DOSAGE FORM. PACKAGE OF 30 PREPARED BY REPACKAGING THE BULK PRODUCT. THE NSN IS NOT PROCURABLE, DO NOT REQUISITION
Related Searches:
CHLOROQUINE PHOSPHATE TABLETS
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160959
NSN
6505-01-516-0959
CHLOROQUINE PHOSPHATE TABLETS
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160959
NSN
6505-01-516-0959
MFG
DISPENSING SOLUTIONS INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500 MG BT 30S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR PROPHYLAXIS AND TREATMENT OF ACUTE ATTACKS OF MALARIA CAUSED BY PLASMODIUM VIVAX, P MALARIAE, P OVALE AND SUSCEPTIBLE STRAINS OF P FALCIPARUM; EXTRAINTESTINAL AMEBIASIS; WITH CHILD PROOF CAP; NSN WAS CREATED TO PERMIT INVENTROY MANAGEMENT OF THE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: REPACKAGED DOSAGE FORM. PACKAGE OF 30 PREPARED BY REPACKAGING THE BULK PRODUCT. THE NSN IS NOT PROCURABLE, DO NOT REQUISITION
Related Searches:
03-2736
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160961
NSN
6505-01-516-0961
03-2736
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160961
NSN
6505-01-516-0961
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500 MG BT 4 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR PROPHYLAXIS AND TREATMENT OF ACUTE ATTACKS OF MALARIA CAUSED BY PLASMODIUM VIVAX, P MALARIAE, P OVALE AND SUSCEPTIBLE STRAINS OF P FALCIPARUM; EXTRAINTESTINAL AMEBIASIS; WITH CHILD PROOF CAP; NSN WAS CREATED TO PERMIT INVENTORY MANAGEMENT OF THE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: REPACKAGED DOSAGE FORM. PACKAGE OF 4 PREPARED BY REPACKAGING THE BULK PRODUCT. THE NSN IS NOT PROCURABLE, DO NOT REQUISITION
Related Searches:
CHLOROQUINE
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160961
NSN
6505-01-516-0961
CHLOROQUINE
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160961
NSN
6505-01-516-0961
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500 MG BT 4 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR PROPHYLAXIS AND TREATMENT OF ACUTE ATTACKS OF MALARIA CAUSED BY PLASMODIUM VIVAX, P MALARIAE, P OVALE AND SUSCEPTIBLE STRAINS OF P FALCIPARUM; EXTRAINTESTINAL AMEBIASIS; WITH CHILD PROOF CAP; NSN WAS CREATED TO PERMIT INVENTORY MANAGEMENT OF THE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: REPACKAGED DOSAGE FORM. PACKAGE OF 4 PREPARED BY REPACKAGING THE BULK PRODUCT. THE NSN IS NOT PROCURABLE, DO NOT REQUISITION
Related Searches:
CHLOROQUINE PHOSPHATE TABLETS
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160961
NSN
6505-01-516-0961
CHLOROQUINE PHOSPHATE TABLETS
CHLOROQUINE PHOSPHATE TABLETS,USP
NSN, MFG P/N
6505015160961
NSN
6505-01-516-0961
MFG
DISPENSING SOLUTIONS INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROQUINE PHOSPHATE TABLETS USP 500 MG BT 4 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR PROPHYLAXIS AND TREATMENT OF ACUTE ATTACKS OF MALARIA CAUSED BY PLASMODIUM VIVAX, P MALARIAE, P OVALE AND SUSCEPTIBLE STRAINS OF P FALCIPARUM; EXTRAINTESTINAL AMEBIASIS; WITH CHILD PROOF CAP; NSN WAS CREATED TO PERMIT INVENTORY MANAGEMENT OF THE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: REPACKAGED DOSAGE FORM. PACKAGE OF 4 PREPARED BY REPACKAGING THE BULK PRODUCT. THE NSN IS NOT PROCURABLE, DO NOT REQUISITION
Related Searches:
XIGRIS NDC 0002-7559-01
DROTECOGIN ALFA
NSN, MFG P/N
6505015162417
NSN
6505-01-516-2417
XIGRIS NDC 0002-7559-01
DROTECOGIN ALFA
NSN, MFG P/N
6505015162417
NSN
6505-01-516-2417
MFG
CATALYTICA /DSM/ PHARMACEUTICALS INC
Description
SPECIAL FEATURES: STORE IN REFIGERATOR; 5MG/5ML
XIGRIS NDC0002-7561-01
DROTRECOGIN ALFA
NSN, MFG P/N
6505015162426
NSN
6505-01-516-2426
XIGRIS NDC0002-7561-01
DROTRECOGIN ALFA
NSN, MFG P/N
6505015162426
NSN
6505-01-516-2426
MFG
CATALYTICA /DSM/ PHARMACEUTICALS INC
Description
SPECIAL FEATURES: STORE IN REFIGERATOR; 20MG/20ML
